Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07735039) titled 'Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)' on July 24.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital

Condition: Human Papillomavirus Infection Cervical Intraepithelial Neoplasia (CIN) Low-Grade Squamous Intraepithelial Lesions

Intervention: Drug: Oral Immunomodulator Drug: Vaginal Ovule

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 28, 2026

Target Sample Size: 76 ...